Literature DB >> 1833457

Human Fc gamma RI and Fc gamma RII interact with distinct but overlapping sites on human IgG.

J Lund1, G Winter, P T Jones, J D Pound, T Tanaka, M R Walker, P J Artymiuk, Y Arata, D R Burton, R Jefferis.   

Abstract

Cellular receptors for IgG (Fc gamma R) mediate important protective functions. By using site-specific mutants of a chimeric antibody (mouse V H domain and L chain; human IgG3 C H domains), we have demonstrated that human Fc gamma RI interacts with a site in the lower hinge of human IgG (residues 234 to 237) and that this interaction dictates Fc gamma RI-mediated superoxide generation. Mutations at position 235 resulted in the most profound reductions in Fc gamma RI recognition. We have also mapped an interaction site for Fc gamma RII to the same region; however, mutations at position 234 and 237 resulted in the greatest reductions in Fc gamma RII recognition. The two receptors appear to recognize overlapping but nonidentical sites on the lower hinge of IgG. Deviations from the optimal motif 234-Leu-Leu-Gly-Gly-237 may then explain the human IgG subclass specificity profile for human Fc gamma RI and Fc gamma RII.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1833457

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  41 in total

1.  Development of a specific system for targeting protein to metallophilic macrophages.

Authors:  Philip R Taylor; Susanne Zamze; Richard J Stillion; Simon Y C Wong; Siamon Gordon; Luisa Martinez-Pomares
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-05       Impact factor: 11.205

2.  Differential functional effects of a humanized anti-CD4 antibody on resting and activated human T cells.

Authors:  S J Brett; W Rowan; M Smith; M Bartholomew; J P Tite
Journal:  Immunology       Date:  1997-07       Impact factor: 7.397

3.  The solution structures of two human IgG1 antibodies show conformational stability and accommodate their C1q and FcγR ligands.

Authors:  Lucy E Rayner; Gar Kay Hui; Jayesh Gor; Richard K Heenan; Paul A Dalby; Stephen J Perkins
Journal:  J Biol Chem       Date:  2015-02-06       Impact factor: 5.157

4.  Effector function activities of a panel of mutants of a broadly neutralizing antibody against human immunodeficiency virus type 1.

Authors:  M Hezareh; A J Hessell; R C Jensen; J G van de Winkel; P W Parren
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

5.  The N-terminal end of the CH2 domain of chimeric human IgG1 anti-HLA-DR is necessary for C1q, Fc gamma RI and Fc gamma RIII binding.

Authors:  A Morgan; N D Jones; A M Nesbitt; L Chaplin; M W Bodmer; J S Emtage
Journal:  Immunology       Date:  1995-10       Impact factor: 7.397

6.  Functional analysis of the effects of a fully humanized anti-CD4 antibody on resting and activated human T cells.

Authors:  M Bartholomew; S Brett; K Barber; C Rossman; S Crowe; J Tite
Journal:  Immunology       Date:  1995-05       Impact factor: 7.397

7.  Activation of effector functions by immune complexes of mouse IgG2a with isotype-specific autoantibodies.

Authors:  E Rajnavölgyi; G Fazekas; J Lund; M Daeron; J L Teillaud; R Jefferis; W H Fridman; J Gergely
Journal:  Immunology       Date:  1995-04       Impact factor: 7.397

8.  Trypanosoma cruzi amastigote adhesion to macrophages is facilitated by the mannose receptor.

Authors:  S Kahn; M Wleklinski; A Aruffo; A Farr; D Coder; M Kahn
Journal:  J Exp Med       Date:  1995-11-01       Impact factor: 14.307

Review 9.  Antibody engineering to develop new antirheumatic therapies.

Authors:  John D Isaacs
Journal:  Arthritis Res Ther       Date:  2009-05-19       Impact factor: 5.156

10.  A modified hybridoma technique for production of monoclonal antibodies having desired isotypes.

Authors:  Napaporn Apiratmateekul; Ponrat Phunpae; Watchara Kasinrerk
Journal:  Cytotechnology       Date:  2009-07-29       Impact factor: 2.058

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.